The global wound dressings market is expected to experience significant growth over the forecast period due to the increasing prevalence of chronic and acute wounds, advancement in wound dressing technologies, and growing demand for advanced wound management products. Wound dressings are medical products that are used to protect wounds and facilitate healing. They are available in a variety of forms such as foam dressings, hydrocolloid dressings, alginate dressings, film dressings, hydrogel dressings, and others.

 Currently, Wound Dressings Market is projected to reach USD 11.2 billion by 2025 from USD 7.0 billion in 2020, at a CAGR of 9.7% during the forecast period. The growth of this market is majorly driven by the growing prevalence of chronic diseases and conditions affecting wound healing capabilities, increasing spending on surgical and chronic wounds, high rate of cesarean sections in elderly women, and the rising incidence of burn injuries. However, the high cost and low adoption rate of advanced wound dressings are expected to restrain the growth of this market during the forecast period.

As the prevalence of chronic and acute wounds increase, the demand for wound dressings is expected to rise, resulting in growth in the wound dressings market. Also, the advancement in wound dressing technologies, such as the development of advanced wound care products, and the increasing awareness of wound management products, are expected to contribute to the growth of the wound dressings market.

The rising demand for advanced wound management products and the increasing prevalence of diabetic ulcers are also expected to propel the growth of the wound dressings market. In addition, the increasing demand for advanced wound dressings that offer better comfort and improved healing are also expected to drive the growth of this market.

Furthermore, the increasing use of wound dressings in the home care setting, the growing demand for cost-effective wound dressings, and the rising awareness about the benefits of wound dressings are also expected to contribute to the growth of the wound dressings market.

Overall, the global wound dressings market is expected to experience significant growth over the forecast period, driven by the increasing prevalence of chronic and acute wounds, advancement in wound dressing technologies, and growing demand for advanced wound management products.

Request for assumptions & how numbers were triangulated.

https://www.marketsandmarkets.com/requestsampleNew.asp?id=123903496

Advanced wound dressings segment dominated the wound dressings market in 2019

Based on type, the wound dressings market is segmented into traditional wound dressings and advanced wound dressings. The advanced wound dressings segment accounted for the largest share of this market in 2019, primarily due to an increase in the incidence of diseases such as diabetic ulcers, venous ulcers, and pressure ulcers; increasing number of surgical procedures; growing patient awareness; and increasing incidences of burn injuries.

Hospitals, ASCs, and clinics segment to register the highest growth in the wound dressings market, by end user

Based on end users, the wound dressings market is segmented into hospitals, ASCs, and clinics; home care settings; and other end users. The hospitals, ASCs, and clinics segment accounted for the largest share of the wound dressings market in 2019. The large share of this segment can be attributed to the rising geriatric population and the subsequent increase in the prevalence of age-related conditions and a large number of treatment procedures carried out in hospitals.

Download an Illustrative Overview:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=123903496

Recent Developments

  • In January 2020, ConvaTec announced the launch of ConvaMax, which helps in managing highly exuding wounds, including leg ulcers, surgical wounds, and diabetic foot ulcers.
  • In September 2018, ConvaTec received the US FDA 510(k) clearance for its AQUACEL Ag Advantage antimicrobial dressings.
  • In November 2018, Molnlycke introduced the Mepilex Border Flex dressing engineered to support fewer dressing changes and reduce dressing costs and waste while creating an optimal healing environment.

Content Source:

https://www.marketsandmarkets.com/Market-Reports/immunotherapy-drug-market-137717755.html

https://www.prnewswire.com/news-releases/immunotherapy-drugs-market-worth-274-6-billion-by-2025--exclusive-report-by-marketsandmarkets-301067599.html

https://mnmblog.org/who-are-the-key-manufacturers-in-the-immunotherapy-drugs-market.html